A Strategic Analysis of Development Opportunities for NeoControl Pelvic Floor Therapy System in Canada

Urinary incontinence is an important health problem that affects millions of Canadians and many millions of people in all age groups worldwide. It is a demoralizing and costly problem with widespread human, social and financial implications. There are various types of treatments available to improve and control incontinence. The NeoControl Pelvic Floor Therapy System provides a non-surgical, non-invasive therapy for treatment of urinary incontinence. Unlike other treatments, NeoControl exercises all the muscles of the pelvic floor to rebuild strength by repeating a painless and easy procedure. The number of Canadians suffering from incontinence is growing because the population is aging. NeoControl and its technology is a new way of treatment, which has not been introduced to the Canadian marketplace to date. This project investigates the opportunity to introduce the NeoControl Pelvic Floor Therapy System to the Canadian marketplace. The study presents an estimate for the demand for the therapy, a strategic evaluation of the market using Porter’s Five Forces Framework, and a description of the target markets. The project concludes with a financial analysis of a proposed business to import and distribute the device into Canada.